Literature DB >> 26031236

Wilson's disease caused by alternative splicing and Alu exonization due to a homozygous 3039-bp deletion spanning from intron 1 to exon 2 of the ATP7B gene.

Eva Mameli1, Maria Barbara Lepori1, Francesca Chiappe1, Giusy Ranucci2, Fabiola Di Dato2, Raffaele Iorio2, Georgios Loudianos3.   

Abstract

We describe a case of Wilson's disease (WD) diagnosed at 5 years after routine biochemical test showed increased aminotransferases. Mutation analysis of the ATP7B gene revealed a 3039-bp deletion in the homozygous state spanning from the terminal part of intron 1 to nt position 368 of exon 2. This deletion results in the activation of 3 cryptic splice sites: an AG acceptor splice site in nt positions 578-579 producing a different breakpoint and removing the first 577 nts of exon 2, an acceptor and a donor splice site in nt positions 20363-4 and 20456-7, respectively, in intron 1, resulting in the activation of a 94-bp cryptic Alu exon being incorporated into the mature transcript. The resulting alternative transcript contains a TAG stop codon in the first amino acid position of the cryptic exon, likely producing a truncated, non-functional protein. This study shows that intron exonization can also occur in humans through naturally occurring gross deletions. The results suggest that the combination of DNA and RNA analyses can be used for molecular characterization of gross ATP7B deletions, thus improving genetic counseling and diagnosis of WD. Moreover these studies help to better establish new molecular mechanisms producing Wilson's disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP7B; Alternative splicing; Deletion; Diagnosis; Exonization; Wilson's disease

Mesh:

Substances:

Year:  2015        PMID: 26031236     DOI: 10.1016/j.gene.2015.05.067

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Alu RNA and their roles in human disease states.

Authors:  Daniel Gussakovsky; Sean A McKenna
Journal:  RNA Biol       Date:  2021-10-21       Impact factor: 4.766

2.  Identification and characterization of a novel 43-bp deletion mutation of the ATP7B gene in a Chinese patient with Wilson's disease: a case report.

Authors:  Gang Liu; Dingyuan Ma; Jian Cheng; Jingjing Zhang; Chunyu Luo; Yun Sun; Ping Hu; Yuguo Wang; Tao Jiang; Zhengfeng Xu
Journal:  BMC Med Genet       Date:  2018-04-12       Impact factor: 2.103

3.  Genetic studies discover novel coding and non-coding mutations in patients with Wilson's disease in China.

Authors:  Chenjun Huang; Meng Fang; Xiao Xiao; Zhiyuan Gao; Ying Wang; Chunfang Gao
Journal:  J Clin Lab Anal       Date:  2022-04-25       Impact factor: 3.124

4.  Intragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis.

Authors:  Theodor Todorov; Prahlad Balakrishnan; Alexey Savov; Piotr Socha; Hartmut H J Schmidt
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 5.  Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.

Authors:  Peter A Larsen; Kelsie E Hunnicutt; Roxanne J Larsen; Anne D Yoder; Ann M Saunders
Journal:  Chromosome Res       Date:  2018-02-19       Impact factor: 5.239

6.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

7.  Novel compound heterozygote mutations in the ATP7B gene in an Iranian family with Wilson disease: a case report.

Authors:  Omid Daneshjoo; Masoud Garshasbi
Journal:  J Med Case Rep       Date:  2018-03-15

8.  A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using next‑generation sequencing and Sanger sequencing.

Authors:  Wei-Liang Liu; Fang Li; Lu Liu; Wei Chen; Zhi-Xu He; Hao Gu; Rong Ai
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.